
(1) GLU 03: Threshold of 65%
(2) PAIN 02: Threshold of 70%
(3) SUS 01: Threshold of 80%
c) New Additional VBR focus area: Smoking Cessation
i) Measurement period: 12/1/2021-11/30/2022
ii) New additional reimbursement: 2% (on top of the potential 5%)
iii) Proposed New Measures (not yet approved by BCBSM):
iv) Improve smoking status documentation within 30 days prior to surgery. Target: 70%
v) Increase the proportion of smokers who receive treatment/cessation counseling. Target: 1%
6) Measure Updates and Feedback
a) PONV Update
i) May 2021 Quality Committee Discussion
(1) 4th Consensus Guidelines for the Management of PONV released August 2020 in
Anesthesia and Analgesia
(2) New guidelines provide updates to both risk factors and prophylaxis recommendations
for adult and pediatrics
(3) Pediatric PONV prophylaxis measure (PONV 04) released in August
(4) Adult PONV prophylaxis measure in progress- need additional guidance before release
ii) PONV 05 - Adult Prophylaxis measure updates
(1) Since the May meeting, adult prophylaxis measure has been coded and validated
(2) Added criterion for cesarean delivery cases based upon SOAP guidelines:
(a) At least 2 prophylactic pharmacologic antiemetic agents from different classes given
preop or intraop (regardless of risk factors)
(3) Initially removed inclusion criteria for general anesthesia as MPOG analysis and 2020
guidelines support assessment of risk factors in patients without GA. However, PONV 05
performance across sites ranges 10-60%. Several MAC cases are currently flagged for
only having 1 risk factor and not receiving 2 antiemetics as prophylaxis
(4) MPOG Coordinating Center proposes updating the specification to only include GA cases
for the updated version of the new measure. New specification would read as follows:
(a) Percentage of patients, aged 18 years and older undergoing a procedure requiring
general anesthesia and administered appropriate prophylaxis for postoperative
nausea and vomiting, as defined by:
(i) At least two prophylactic pharmacologic antiemetic agents of different classes
administered preoperatively or intraoperatively for patients with one or two risk
factors
(ii) At least three or more prophylactic pharmacologic antiemetic agents from
different classes preoperatively or intraoperatively for patients with three or
more risk factors
(iii) For cesarean delivery cases only: At least two prophylactic pharmacologic
antiemetic agents from different classes preoperatively or intraoperatively.
(5) Limitations and Next Steps
(a) The measure will ignore MAC cases that could potentially result in postop nausea
and vomiting for this initial version of PONV 05
(b) Further analysis and discussion to address MAC cases can be done later
(6) Chat comments: